In a study just published, researchers have shown for the first time that early treatment can slow the rate at which disability progresses in individuals who have had a first event suggestive of multiple sclerosis but who have not yet been diagnosed with definite MS. The study is a follow-up to the completed, two-year BENEFIT study.